Skip to main content
Clinical Trials/ACTRN12609000621213
ACTRN12609000621213
Completed
Phase 2

Does Suprascapular Nerve Block Reduce Shoulder Pain Following Stroke: A single-blind randomised controlled trial with measured outcome assessment.

Maria Crotty0 sites66 target enrollmentJuly 27, 2009

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Stroke
Sponsor
Maria Crotty
Enrollment
66
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 27, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Maria Crotty

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria will be all willing patients aged over 18 years and able to give consent with a diagnosis of acute stroke with the previous 12 months and onset of hemiplegic shoulder pain post stroke with a visual analogue scale score of \>30mm (100mm scale)

Exclusion Criteria

  • Cognitive deficit that preclude patients
  • from reliably using subjective outcome measures scales \- Mini\-Mental State Examination (MMSE) \< 23\.
  • Language deficits (inability to follow 2\-
  • stage command) or limited English language that preclude patients from reliably using subjective outcome measures scales
  • Allergy to proposed injection agents (depo\-medrol 40mg and 0\.5% bupivocaine hydrocholoride)

Outcomes

Primary Outcomes

Not specified

Similar Trials